BCAX Bicara Therapeutics Inc. Common Stock
$23.09
▼ 2.90%
34
Value
30
P/E-9.23
8
P/B3.17
46
P/S0.00
70
EV/EBITDA-7.74
5
Growth
34
Revenue Growth0.0%
28
EPS Growth-101.6%
36
FCF Growth-43.2%
39
Momentum
81
12-Month Return82.2%
100
3-Month Return52.9%
100
1-Month Return6.8%
66
RSI (14)43.39
50
50/200 MABullish
75
Profitability
19
ROE-32.5%
45
ROA-32.0%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-8.5%
0
Risk
5
Beta-0.56
10
60-Day Volatility47.6%
0
QScore Analysis